Zentalis Pharmaceuticals, Inc. Common Stock — Institutional Ownership

Which tracked institutions hold ZNTL, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

20
Funds holding
$43704748
Total value held
Buying
14 added/new · 5 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $18204597 3753525 +2483688 +195.59%
2 Bank Of America Corp /De/ $5406053 1114650 -17644 -1.56%
3 State Street Corp $4303968 887416 +637726 +255.41%
4 Pfizer Inc $3853489 953834 Held
5 Morgan Stanley $2285563 471250 +121043 +34.56%
6 Northern Trust Corp $1883251 388299 +270113 +228.55%
7 Goldman Sachs Group Inc $1806936 372564 -90114 -19.48%
8 Ubs Group Ag $1442283 297378 +297378 NEW BUY
9 Sei Investments Co $1241983 256079 +64528 +33.69%
10 Invesco Ltd. $784037 161657 +161657 NEW BUY
11 Barclays Plc $770452 158856 -432361 -73.13%
12 Bank Of New York Mellon Corp $592030 122068 +122068 NEW BUY
13 Federated Hermes, Inc. $478292 98617 +98617 NEW BUY
14 Wells Fargo & Company/Mn $203202 41898 +41897 +4189700.00%
15 Toronto Dominion Bank $114295 23566 +23566 NEW BUY
16 Citigroup Inc $112093 23112 +23112 NEW BUY
17 Raymond James Financial Inc $110507 22785 -110 -0.48%
18 Jpmorgan Chase & Co $103443 22439 -90687 -80.16%
19 Royal Bank Of Canada $8000 1636 +1538 +1569.39%
20 Amalgamated Financial Corp. $274 5945 +5945 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.